Lopinavir
Signals from filings dated January 2026 – January 2026 · Last checked 7 Nov 2026
Supply outlook
↓ SHRINKINGIn the filings we track: 0 plants adding this molecule, 1 exit signal, 0 intermediate projects.
Signals
Fusion Health Care Pvt. Ltd.
Sy. No. 667, Bhiknoor, Kamareddy, Telangana
- ✓ Terms of reference
- ✓ Public hearing · 7 Jan 2026
- Next: clearance
- Consent to operate
- DMF / CEP
Filed as lapinavir (sic). Capacity 166.67 → 100 kg/day (-66.67). Expansion of an approved API unit still under construction (EC 2021; taken over by Fusion Health Care in 2023). Worst case 6 products run at once; site total 1,000 to 2,420 kg/day. Public hearing held 7 Jan 2026. Source: EIA executive summary, TGPCB
Who makes Lopinavir today: 17 listings
Current manufacturers with US DMF and CEP status, plant addresses and contacts.
| Manufacturer | Country | US DMF | CEP | Contact |
|---|---|---|---|---|
| Aurobindo Pharma Ltd | India | ✓ | ✓ | In database |
| Mylan N.V. | United States | ✓ | — | In database |
| Anhui Biochem United Pharmaceutical Co.,Ltd | China | — | — | In database |
| + 14 more listings in api-fdf.com → | ||||
Three examples from the api-fdf.com database, refreshed weekly. Plant addresses and contacts are shown in the database.
Follow Lopinavir
Get an email when a new filing adds, cuts or moves this molecule to the next stage.